Cancer cells that survived after initial cycles acquire resistance through multiple cellular mechanisms such as activation of NF-κB, PI3K, Akt, and mTOR [187] but the resistance to radiotherapy in GBM is primarily attributed to EGFRvIII. This evidence concerns the gene MTOR and cancer.